<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02800772</url>
  </required_header>
  <id_info>
    <org_study_id>ERCP-01</org_study_id>
    <nct_id>NCT02800772</nct_id>
  </id_info>
  <brief_title>Impact of Intraduodenal Acetic Acid Infusion on Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography: a Double-blind, Randomized Controlled Trial</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intraduodenal acetic acid can stimulate secretion of water and bicarbonate from pancreatic
      ductal cells. In this study, acetic acid spraying to duodenal bulb was compared with saline
      solution for the facilitation of pancreatic duct cannulation in patients.The primary outcome
      was successful deep pancreatic duct cannulation. The secondary outcomes were the appearance
      of the major and minor papillary orifice, pancreatic juice flow from the papilla, time to
      achieve deep pancreatic duct cannulation, and fluoroscopy time for deep pancreatic duct
      cannulation in the acetic acid group versus saline group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2016</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cannulation time for deep pancreatic duct cannulation</measure>
    <time_frame>2 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fluoroscopy time for deep pancreatic duct cannulation</measure>
    <time_frame>2 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pancreatic juice flow from the major papilla</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>appearance of the major papillary orifice</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">210</enrollment>
  <condition>Pancreatic Duct Cannulation During Endoscopic Retrograde Choledochopancreatography</condition>
  <arm_group>
    <arm_group_label>acetic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>spray 50ml acetic acid to duodenal bulb</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>spray 50ml saline to duodenal bulb</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>acetic acid</intervention_name>
    <arm_group_label>acetic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>saline</intervention_name>
    <arm_group_label>saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion criteria were(1)those with intact native papilla (2)who underwent endoscopic
             retrograde choledochopancreatography for pancreatic duct, (3)age≥18 years，≦80years,and
             (4)agreement to participate in the study.

        Exclusion Criteria:

          -  Exclusion criteria were (1) a previous sphincterotomy, (2) previous attempted or
             unsuccessful endoscopic retrograde choledochopancreatography with papillary
             manipulation, (3) indwelling biliary or pancreatic stent(s), (4) active acute
             pancreatitis, (5) altered/postsurgical anatomy, (6) history of gastroparesis, and (7)
             endoscopic retrograde choledochopancreatography for sphincter of Oddi (SO) manometry.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2016</study_first_submitted>
  <study_first_submitted_qc>June 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2016</study_first_posted>
  <last_update_submitted>November 14, 2017</last_update_submitted>
  <last_update_submitted_qc>November 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Zhaoshen Li</investigator_full_name>
    <investigator_title>Digestive Endoscopy Center</investigator_title>
  </responsible_party>
  <keyword>pancreatic duct</keyword>
  <keyword>ERCP</keyword>
  <keyword>acetic acid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinol acetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

